Calendar argenx SE

Equities

ARGX

NL0010832176

Market Closed - Euronext Bruxelles 11:39:38 2024-06-24 EDT 5-day change 1st Jan Change
405.5 EUR +9.06% Intraday chart for argenx SE +14.03% +18.05%

Chart calendar argenx SE

3446c8b321e9.6xvz7lbw5cp7EQKlwZR0PW8FRnPXq-fvHzO4BkLQt30.mm6Qpz-j1oEdI0HkheJDfwhNEB--zoCKXlHKZSf95k2Fep-nZrvSnTMhYQ~82ec289c6c855a5eb486de89edcb46a1

Upcoming events on argenx SE

2024-07-16 08:30 R&D Day
2024-07-25 01:00 Q2 2024 Earnings Release
2024-10-24 01:00 Q3 2024 Earnings Release
2025-02-26 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)
2025-07-23 Q2 2025 Earnings Release (Projected)
2025-10-22 Q3 2025 Earnings Release (Projected)

Past events on argenx SE

2024-06-21 17:00 VYVGART Hytrulo FDA Approval Call
2024-06-11 14:40 Goldman Sachs Global Healthcare Conference
2024-05-14 13:00 BofA Securities Health Care Conference
2024-05-09 08:30 Q1 2024 Earnings Call
2024-05-09 01:00 Q1 2024 Earnings Release
2024-05-07 07:00 Annual General Meeting
2024-04-17 17:42 American Academy of Neurology Meeting - Neelam Goyal
2024-04-17 13:45 American Academy of Neurology Meeting - Jana Podhorna
2024-04-17 13:45 American Academy of Neurology Meeting - Srikanth Muppidi
2024-04-17 13:45 American Academy of Neurology Meeting - Vera Bril
2024-04-17 13:45 American Academy of Neurology Meeting - Jana Podhorna
2024-04-16 11:15 American Academy of Neurology Meeting - Jeffrey Allen
2024-04-15 13:45 American Academy of Neurology Meeting - James Howard
2024-04-15 13:45 American Academy of Neurology Meeting - Tuan Vu
2024-03-12 15:35 Barclays Global Healthcare Conference
2024-03-11 14:40 Leerink Partners Global Biopharma Conference
2024-03-04 11:10 TD Cowen Health Care Conference
2024-02-29 08:30 Q4 2023 Earnings Call
2024-02-29 01:00 Q4 2023 Earnings Release
2024-01-08 12:00 JPMorgan Healthcare Conference

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
82,6
80,2
2.96%
54,5
59,0
-7.57%
486
450
8.14%
420
400
5.04%
1 171
1 111
5.41%

1 726

EBITDA
Million EUR
Released
Forecast
Spread
-176
-139
-27.19%
-414
-407
-1.74%
-310
-320
3.13%
-580
-671
13.54%
-290
-325
10.69%

-252

EBIT
Million EUR
Released
Forecast
Spread
-179
-143
-24.77%
-418
-424
1.51%
-314
-332
5.44%
-679
-709
4.21%
-392
-344
-13.9%

-242

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-158
-105
-50.8%
-526
-471
-11.77%
-360
-355
-1.6%
-688
-797
13.67%
-281
-288
2.4%

-140

Net income
Million EUR
Released
Forecast
Spread
-163
-106
-53.34%
-529
-484
-9.2%
-368
-368
0.1%
-669
-786
14.88%
-272
-245
-11.08%

-153

EPS
EUR
Released
Forecast
Spread
-4,22
-2,64
-60.08%
-11,7
-10,7
-8.98%
-7,20
-6,76
-6.61%
-12,3
-14,1
12.95%
-4,76
-4,30
-10.67%

-2,45

Announcement Date27/02/2004/03/2103/03/2202/03/2329/02/24-

Quarterly results

Fiscal PeriodDecember 2019 S2 2021 Q4 2021 S2 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2022 S2 2023 Q1 2023 Q2 2023 S1 2023 Q3 2023 Q4 2023 S2 2024 Q1 2024 Q2 2024 S1 2024 Q3 2024 Q4 2024 S2 2025 Q1
Net sales
Million EUR
Released
Forecast
Spread
31,3
41,3
-24.34%
40,4
16,4
146.37%



29,8
14,5
105.62%
84,1
42,3
98.63%
146
118
23.22%
172
167
2.58%
310
302
2.69%
208
180
15.15%
254
229
11.05%
461
448
3.08%
320
286
12.17%
386
336
14.74%
699
675
3.62%
384
374
2.76%

406


791


445


486


902


510

EBITDA
Million EUR
Released
Forecast
Spread



-198
-204
2.85%



-212
-249
14.93%
-170
-264
35.5%
-208
-204
-2.09%

-114





-104


-95,5








-69,0





-70,6


-93,1





-99,0


-61,5







EBIT
Million EUR
Released
Forecast
Spread
-94,1
-46,2
-103.63%
-208
-226
8.04%



-211
-250
15.55%
-172
-244
29.44%
-207
-194
-6.78%
-108
-136
20.55%
-305
-312
2.28%
-93,8
-116
18.88%
-92,2
-89,9
-2.61%
-186
-160
-16.48%
-76,0
-89,9
15.5%
-128
-88,5
-44.54%
-202
-128
-57.93%
-86,9
-57,3
-51.81%

-78,8


-170


-58,3


-36,5


-147


7,11

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
-113
-42,8
-165.01%
-221
-228
3.12%



-218
-248
12.03%
-214
-235
8.97%
-239
-193
-23.81%
-38,9
-158
75.37%
-266
-344
22.52%
-68,9
-110
37.55%
-75,7
-77,8
2.65%
-145
-154
6.04%
-78,5
-78,7
0.26%
-56,5
-74,5
24.24%
-133
-110
-21.02%
-69,2
-37,2
-85.79%

-59,5


-63,4


-31,6


-12,6


-55,3


20,8

Net income
Million EUR
Released
Forecast
Spread
-118
-42,8
-175.29%
-214
-219
2.01%
-425
-416
-2.28%
-215
-248
13.23%
-206
-235
12.27%
-233
-194
-20.18%
-36,4
-159
77.14%
-258
-335
22.97%
-26,1
-113
76.84%
-85,2
-76,7
-11.16%
-111
-154
27.65%
-68,5
-82,3
16.8%
-91,5
-71,0
-28.87%
-159
-110
-43.94%
-57,3
-38,2
-50.18%

-55,4


-63,4


-33,5


-18,2


-55,3


31,5

EPS
EUR
Released
Forecast
Spread



-4,29
-3,76
-14.1%






-3,76
-4,59
18.08%
-4,23
-5,03
15.84%
-0,66
-3,14
78.97%



-0,47
-2,44
80.76%
-1,53
-1,62
5.73%



-1,18
-2,14
45.04%
-1,55
-2,16
28.16%




-0,60


-0,94





-0,98


-0,55







Announcement Date27/02/2003/03/2203/03/2205/05/2228/07/2227/10/2202/03/2302/03/2304/05/2327/07/2327/07/2331/10/2329/02/2429/02/2409/05/24------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise